NeoCare Readying for Canadian Trials

After successful medical trials in India, Halifax's NeoCare is aiming to recreate the promising results in Canada as it looks to secure regulatory approval and close a $750,000 funding round.
NeoCare’s flagship product is SAMIRA — a system that uses light shone through a newborn’s thumb to test for jaundice, anemia and hypoxia, all of which are leading causes of infant mortality globally.